secwatch.observer — SEC 8-K summary
======================================

Issuer:     KORU Medical Systems, Inc. (KRMD)
CIK:        0000704440
Form:       8-K
Filed at:   2026-03-12T23:59:59+00:00
Accession:  0001161697-26-000051
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

KORU Medical reports 22% FY2025 revenue growth; positive adjusted EBITDA; initiates FY2026 guidance
--------------------------------------------------------------------------------

- Q4 2025 net revenue $10.9M (+23% YoY); FY2025 net revenue $41.1M (+22% YoY).
- International Core revenue grew 80% in FY2025; Domestic Core grew 11%.
- FY2025 net loss narrowed 57% to $2.6M ($0.06 loss per share); positive adjusted EBITDA of $0.6M.
- Cash and cash equivalents $8.9M at Dec 31, 2025; used only $0.7M cash in FY2025.
- FY2026 guidance: net revenue $47.5–$50.0M (15–22% growth); positive adjusted EBITDA and positive cash flow.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/704440/000116169726000051/0001161697-26-000051-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/704440/000116169726000051/form_8-k.htm
  HTML page:      https://secwatch.observer/filing/0001161697-26-000051

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer